Lv41
426 积分 2025-08-03 加入
P503 MEPOLIZUMAB FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS: COMORBID ASTHMA, NSAID EXACERBATED RESPIRATORY DISEASE, EOSINOPHIL STRATIFICATION
21分钟前
求助中
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
3小时前
已完结
Effects of Different Types of Medications on Olfactory Dysfunction in CRSwNP : A Systematic Review and Network Meta‐Analysis
1天前
已完结
Efficacy of Reslizumab in Asthma Patients with Aspirin Sensitivity and Elevated Blood Eosinophils
2天前
已完结
P509 RESLIZUMAB AN INTERLEUKIN-5 ANTAGONIST MONOCLONAL ANTIBODY FOR UNCONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
2天前
已完结
A Study of Dupilumab in Adults with CRSsNP: Results from the Liberty ORION study
3天前
已完结
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
6天前
已完结
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
9天前
已完结
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
9天前
已完结
Ultra-long-acting biological therapy for chronic rhinosinusitis with nasal polyps
9天前
已完结
皖公网安备34019202002308
